ArticleInternational journal of nanomedicine2022

Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy.

Peiqi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.